Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Urine test breakthrough: A non-invasive solution to diagnosing heart disease A simple urine test, capable of detecting protein biomarkers, is being hailed as a breakthrough in diagnosing heart… bypharmanewsdailyJanuary 27, 2025